Long-Term Therapy for ‘Low T’ Doesn’t Appear to Increase Prostate Cancer Risk
Androgen-deprivation therapy might be used to treat aggressive prostate cancer. but that doesn’t mean testosterone replacement therapy promotes the disease, according to a new study. In fact, researchers report evidence of lower risk of aggressive prostate cancer with long-term “low T” therapy. Here are the details.